MENU
SCNI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Scinai Immunotherapeutics (SCNI) Ownership - Who owns Scinai Immunotherapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
33
Web
https://www.biondvax.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.9M
P/E Ratio
1.42
Total Cash
1.03M
Projected Growth
N/A
Total Debt
1.23M
Revenue
452K
Risk (Beta)
2.13
Dividend Yield
N/A
Total Cash/Share
1.21
Total Debt/Equity
N/A
Revenue/Share
0.53 USD as % of share price
Fundamentals
SCNI
Capitalization
2.9M
P/E Ratio
1.42
Risk (Beta)
2.13
Dividend Yield
N/A
Total Cash
1.03M
Total Cash/Share
1.21
Total Debt
1.23M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.53%
Revenue
452K
ROE
N/A
Book Value
4.38M
P/B Ratio
0.66
Cash Flow
N/A
Earnings
2.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
1.16
Current Revenue Per Employee
5419.35
Dividends Per Share - Security
N/A
EBITDA
7.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
-148.21
Revenue To Assets
30.45
Shares Held By Institutions
56.7K
Shares Outstanding - Current
853K
Total Liabilities
2.26M
Total Volume MTD
N/A
Value
1
Gain YTD
-42.895
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of the innovative flu vaccine
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Hadassah Ein Kerem Campus
Phone
+972 89302529
Employees
33
Web
https://www.biondvax.com